GNI GNI GROUP LTD.

Contact Us
About Us
  • About Us TOP
  • Message
  • Business Model
  • Main Products
  • Management Policy
  • Company Overview
  • Board of Directors
  • Main Group Structure
  • Office
  • Corporate governance
R&D
  • R&D TOP
  • Pipeline
  • Discovery Research
  • Research publications
Investor Relations
  • Investor Relations TOP
  • IR News
  • Information
  • IR Materials
  • IR Calendar
  • IR Email Subscription
  • Electronic Public Notices
Sustainability/ESG
  • Sustainability/ESG TOP
  • Sustainability Initiatives
  • ESG Data
Contact Us
Site Map
Privacy Policy
Terms of Use
ソーシャルメディアポリシー

2014's Information

トップページInformation2014年
2014/12/12
Filing of IND for Connective Tissue Disease Associated Interstitial Lung Disease
2014/11/10
Beijing Continent Pharmaceutical Co, Ltd.(our subsidiary company)will attend 2014 APSR.
2014/10/08
Quick View from EDISON
2014/09/29
Notice of Exercise Price of Stock Option etc
2014/09/12
Notice of Granting Stock Option to Board of Directors
2014/09/04
Tokyo Administrative Office Relocation
2014/09/01
Re-assignment of Industry Category
2014/07/01
F351 Phase II Clinical Trial Approval
2014/06/11
World Orphan Drug Congress Asia
2014/05/09
Patent Allowance for Etuary and F351 in the U.S.
  • 1
  • 2
  • 3
  • >
画像

GNI

About Us
Message
Business Model
Main Products
Management Policy
Company Overview
Board of Directors
Main Group Structure
Office
Corporate Governance Policy
Investor Relations
IR News
IR Materials
IR Calendar
Electronic Public Notices
IR Email Subscription
R&D
Pipeline
Discovery Research
Research publications
Sustainability/ESG
Sustainability Initiatives
ESG Data
Contact Us
Career
Site Map
Privacy Policy
Terms of Use
Social Media Policy
Site Map
Privacy Policy
Terms of Use
Social Media Policy

© GNI Group Ltd. All Rights Reserved.